JP2024503623A5 - - Google Patents

Info

Publication number
JP2024503623A5
JP2024503623A5 JP2023541041A JP2023541041A JP2024503623A5 JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5 JP 2023541041 A JP2023541041 A JP 2023541041A JP 2023541041 A JP2023541041 A JP 2023541041A JP 2024503623 A5 JP2024503623 A5 JP 2024503623A5
Authority
JP
Japan
Application number
JP2023541041A
Other languages
Japanese (ja)
Other versions
JPWO2022150485A5 (https=
JP2024503623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011450 external-priority patent/WO2022150485A1/en
Publication of JP2024503623A publication Critical patent/JP2024503623A/ja
Publication of JPWO2022150485A5 publication Critical patent/JPWO2022150485A5/ja
Publication of JP2024503623A5 publication Critical patent/JP2024503623A5/ja
Pending legal-status Critical Current

Links

JP2023541041A 2021-01-06 2022-01-06 カプセル化rnaポリヌクレオチド及び使用方法 Pending JP2024503623A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US202163134376P 2021-01-06 2021-01-06
US63/134,376 2021-01-06
US202163147959P 2021-02-10 2021-02-10
US63/147,959 2021-02-10
US202163181917P 2021-04-29 2021-04-29
US202163181663P 2021-04-29 2021-04-29
US202163181899P 2021-04-29 2021-04-29
US63/181,899 2021-04-29
US63/181,663 2021-04-29
US63/181,917 2021-04-29
PCT/US2022/011450 WO2022150485A1 (en) 2021-01-06 2022-01-06 Encapsulated rna polynucleotides and methods of use

Publications (3)

Publication Number Publication Date
JP2024503623A JP2024503623A (ja) 2024-01-26
JPWO2022150485A5 JPWO2022150485A5 (https=) 2025-02-03
JP2024503623A5 true JP2024503623A5 (https=) 2025-02-03

Family

ID=82357635

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023541041A Pending JP2024503623A (ja) 2021-01-06 2022-01-06 カプセル化rnaポリヌクレオチド及び使用方法

Country Status (7)

Country Link
US (1) US20240115636A1 (https=)
EP (1) EP4274591A4 (https=)
JP (1) JP2024503623A (https=)
KR (1) KR20230143141A (https=)
AU (1) AU2022206676A1 (https=)
CA (1) CA3204244A1 (https=)
WO (1) WO2022150485A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023091490A1 (en) * 2021-11-16 2023-05-25 Senda Biosciences, Inc. Novel ionizable lipids and lipid nanoparticles and methods of using the same
WO2023223183A1 (en) * 2022-05-16 2023-11-23 Crispr Therapeutics Ag Picornaviral vectors for gene editing
WO2024031078A2 (en) * 2022-08-05 2024-02-08 Elevatebio Technologies, Inc. Chimeric oncolytic viruses with tropism for poliovirus receptor
EP4612284A2 (en) 2022-11-04 2025-09-10 Life Edit Therapeutics, Inc. Evolved adenine deaminases and rna-guided nuclease fusion proteins with internal insertion sites and methods of use
WO2024162304A1 (ja) 2023-01-31 2024-08-08 アステラス製薬株式会社 環状アミンを有するカルバモイル脂質又はウレア脂質、それを含む脂質ナノ粒子、及び医薬組成物
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
WO2024226832A1 (en) * 2023-04-25 2024-10-31 Orgenesis Inc. Ribonucleases for treating viral infections
WO2025022367A2 (en) 2023-07-27 2025-01-30 Life Edit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
WO2025083619A1 (en) 2023-10-18 2025-04-24 Life Edit Therapeutics, Inc. Rna-guided nucleases and acive fragments and variants thereof and methods of use
TW202546224A (zh) 2024-02-12 2025-12-01 美商生命編輯治療學公司 新穎的rna引導之核酸酶及用於聚合酶編輯之蛋白質
WO2026003754A1 (en) 2024-06-25 2026-01-02 Life Edit Therapeutics, Inc. Novel reverse transcriptases and uses thereof
WO2026006491A1 (en) * 2024-06-25 2026-01-02 Cornell University Senecavirus a (sva) vaccine compositions and methods thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074526A1 (en) * 2005-01-17 2006-07-20 Viralytics Limited Method and composition for treatment of neoplasms
HRP20220652T1 (hr) * 2015-12-10 2022-06-24 Modernatx, Inc. Pripravci i postupci unosa terapijskih sredstava
AU2018301701A1 (en) * 2017-07-14 2020-02-27 Elevatebio Technologies, Inc. Encapsulated polynucleotides and methods of use
WO2019046809A1 (en) * 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
WO2019210394A1 (en) * 2018-04-29 2019-11-07 Precision Nanosystems Inc. Compositions for transfecting resistant cell types
EP3906039A4 (en) * 2019-01-04 2023-01-18 Oncorus, Inc. ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE
EP3956459A4 (en) * 2019-04-15 2023-01-11 Precision Nanosystems Inc NONVIRAL MODIFICATION OF T LYMPHOCYTE GENE EXPRESSION

Similar Documents

Publication Publication Date Title
JP2024503623A5 (https=)
JP2024542188A5 (https=)
CL2025003599A1 (es) Un perno de roca.
BR102022025291A2 (https=)
CL2026000097A1 (es) Aparato, sistema y método para monitorizar los procesos de envejecimiento y/o maceración de una bebida alcohólica en una barrica y bedida alcohólica obtenida
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BY13169U (https=)
BY13163U (https=)
CN307046209S (https=)
CN307044871S (https=)
CN307044820S (https=)
CN307044762S (https=)
CN307044680S (https=)
CN307046681S (https=)
CN307044454S (https=)
CN307044265S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
CN307049411S (https=)